Status:
COMPLETED
Robotic Resection for Patients With Gastric Gastrointestinal Stromal Tumors: a Single-center Study
Lead Sponsor:
JIANG Zhi-Wei
Conditions:
Gastrointestinal Stromal Tumor of Stomach
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Patients with gastric gastrointestinal stromal tumors will receive robotic resection.
Detailed Description
Gastrointestinal stromal tumors are the most common stromal tumors of the digestive tract. Approximately 60% of tumors develop in the stomach.Before, patients with gastric gastrointestinal stromal tum...
Eligibility Criteria
Inclusion
- Requirements of informed consent and assent of participant, parent or legal guardian as applicable.
- Patients with gastric gastrointestinal stromal tumors scheduled for robotic resection and between the age of 18 and 80 years old without considering sex.
- American Society of Anesthesiologists (ASA) physical status I-III.
- Participants can follow the visit plan.
Exclusion
- Patients certified by a doctor that doesn't fit to participate in this study.
- Patients with ischemic heart disease, cerebrovascular disease and peripheral vascular disease, or their cardiac function \> II (NYHA) patients, patients received coronary artery bypass grafting (CABG) recently, and patients with severe hypertension (systolic pressure≥180mmHg or diastolic pressure≥110mmHg).
- Patients with gastrointestinal stromal tumor with distant metastasis.
- Patients with severe infection, respiratory dysfunction, coagulation disorders, severe liver and renal dysfunction (Child - Pugh≥ 10; creatinine clearance \< 25 ml/min).
- Patients with gastrointestinal operations and complicated abdominal operations.
- Patients with severe malnutrition (albumin≤30g/L, weight loss in half a year\>10%, Subjective Global Assessment (SGA) classification C, body mass index \<18, Hb\<70g/L).
- Pregnancy and lactation women, or have a pregnancy plan within a month after the test of the subjects (also including male participants).
- Patients participated other subjects 3 months before this subject.
- Sponsors or researchers directly involved in the testing or their family members.
Key Trial Info
Start Date :
January 10 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2017
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03238820
Start Date
January 10 2014
End Date
June 1 2017
Last Update
August 3 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jinling Hospital, Medical School of Nanjing University
Nanjing, Jiangsu, China, 210002